DNB Fund - Biotechnology A (ACC) EUR

WKN A40FC7 | ISIN LU2814038266 |  Fonds
Factsheet

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU2026682919 Candriam Equities L Biotechnology, V2 - Capitalisation +23,53 % +22,29 % 0,96
2 LU0195948822 Franklin Biotechnology Discovery Fund - I (acc) USD +24,84 % +24,37 % 0,94
3 LU0976566496 Franklin Biotechnology Discovery Fund - W (acc) USD +24,79 % +24,40 % 0,93
4 LU0317020203 Candriam Equities L Biotechnology, V - Capitalisation +22,32 % +22,10 % 0,92
5 LU0108459040 Candriam Equities L Biotechnology C - Thesaurierung +22,14 % +22,28 % 0,90
73 LU2814038266 DNB Fund - Biotechnology A (ACC) EUR +0,54 % +24,62 % -0,06
85 LU0415392678 Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating -7,55 % +14,30 % -0,67
86 LU2719280096 Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 CHF - Accumulating -8,38 % +14,65 % -0,71
87 LU0415392249 Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating -8,19 % +14,29 % -0,71
88 LU0415392835 Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating -8,49 % +14,64 % -0,72
89 LU0415392595 Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating -9,13 % +14,64 % -0,76